Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Marcuello · SciRah

Researcher profile · Semantic Scholar

E. Marcuello

Share profile

E. Marcuello — researcher profile on SciRah

h-index: 27
Works: 87
Citations: 3,951

Most-cited papers

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
D. Cunningham, I. Láng, E. Marcuello, V. Lorusso +7 more
2013The Lancet Oncology615 citations
Semantic Scholar
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer d
C. Fernández-Martos, C. Pericay, J. Aparicio, A. Salud +16 more
2010Journal of Clinical Oncology362 citations Open access
Semantic Scholar
UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer
E. Marcuello, Albert Altés, A. Menoyo, E. del Río +2 more
2004British Journal of Cancer329 citations Open access
Semantic Scholar
K-ras and p16 aberrations confer poor prognosis in human colorectal cancer.
M. Esteller, S. González, R. Risques, E. Marcuello +5 more
2001Journal of Clinical Oncology270 citations
Semantic Scholar
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.
E. Díaz-Rubio, A. Gómez-España, B. Massutí, J. Sastre +21 more
2012The Oncologist218 citations Open access
Semantic Scholar
p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
S. Tórtola, E. Marcuello, I. González, G. Reyes +5 more
1999Journal of Clinical Oncology162 citations
Semantic Scholar
Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil‐based chemotherapy in advanced colorectal cancer patients
E. Marcuello, A. Altés, E. del Río, Angeles César +2 more
2004International Journal of Cancer139 citations Open access
Semantic Scholar
Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients.
E. Roé, M. P. García Muret, E. Marcuello, J. Capdevila +2 more
2006Journal of American Academy of Dermatology138 citations
Semantic Scholar
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
L. Paré, E. Marcuello, A. Altés, E. del Río +5 more
2009British Journal of Cancer114 citations Open access
Semantic Scholar
A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer
E. Marcuello, D. Páez, L. Paré, J. Salazar +3 more
2011British Journal of Cancer110 citations Open access
Semantic Scholar
Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
J. Sastre, E. Marcuello, B. Masutti, M. Navarro +10 more
2005Journal of Clinical Oncology101 citations
Semantic Scholar
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
E. Martínez-Balibrea, A. Abad, A. Martínez-Cardús, A. Ginés +10 more
2010British Journal of Cancer93 citations Open access
Semantic Scholar
Standardized approach for microsatellite instability detection in colorectal carcinomas.
I. González-García, V. Moreno, M. Navarro, J. Martí-Ragué +5 more
2000Journal of the National Cancer Institute93 citations
Semantic Scholar
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
J. Sastre, M. Maestro, A. Gómez-España, F. Rivera +13 more
2012The Oncologist91 citations Open access
Semantic Scholar
Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
J. Hoskins, E. Marcuello, A. Altés, S. Marsh +6 more
2008Clinical Cancer Research78 citations Open access
Semantic Scholar
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
E. Marcuello, Albert Altés, A. Menoyo, E. del Río +1 more
2006Cancer Chemotherapy and Pharmacology78 citations
Semantic Scholar
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.
J. Sastre, C. Grávalos, F. Rivera, B. Massutí +7 more
2012The Oncologist73 citations Open access
Semantic Scholar
K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
M. Céspedes, F. Sancho, S. Guerrero, M. Parreño +7 more
2006Carcinogenesis69 citations Open access
Semantic Scholar
Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer.
R. Risques, V. Moreno, M. Ribas, E. Marcuello +2 more
2003Cancer Research58 citations
Semantic Scholar
Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
R. Arribas, M. Ribas, R. Risques, L. Masramon +6 more
1999Clinical Cancer Research48 citations
Semantic Scholar
Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas
I. Casanova, M. Parreño, L. Farré, S. Guerrero +6 more
2006International Journal of Cancer46 citations Open access
Semantic Scholar
Growing teratoma syndrome: experience of a single institution.
P. (. Maroto, J. M. Tabernero, H. Villavicencio, R. Mesia +8 more
1997European Urology44 citations
Semantic Scholar
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
X. D. del Muro, E. Marcuello, J. Gumà, L. Paz-Ares +6 more
2002British Journal of Cancer43 citations Open access
Semantic Scholar
Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study
E. Díaz-Rubio, A. Gómez-España, B. Massutí, Javier Sastre +14 more
2012PLoS ONE41 citations Open access
Semantic Scholar
Redefining the Significance of Aneuploidy in the Prognostic Assessment of Colorectal Cancer
R. Risques, V. Moreno, E. Marcuello, J. Petriz +5 more
2001Laboratory Investigation37 citations Open access
Semantic Scholar
Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: Are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti‐EGFR‐based therapy?
D. Páez, L. Paré, I. Espinosa, J. Salazar +4 more
2010Cancer Science30 citations Open access
Semantic Scholar
Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
D. Páez, J. Salazar, L. Paré, Lourdes Pertriz +5 more
2011International Journal of Radiation Oncology, Biology, Physics27 citations
Semantic Scholar
Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy
M. A. Izquierdo, E. Marcuello, G. G. De Segura, R. Blanco +3 more
1993Cancer27 citations Open access
Semantic Scholar
Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.
M. Benavides, C. Pericay, M. Valladares-Ayerbes, S. Gil-Calle +16 more
2012Clinical colorectal cancer25 citations Open access
Semantic Scholar
A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
A. Abad, Matilde Navarro, Javier Sastre, E. Marcuello +5 more
1997Oncology24 citations
Semantic Scholar
Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil
D. Páez, L. Paré, A. Altés, F. J. Sancho-Poch +8 more
2010Journal of Cancer Research and Clinical Oncology23 citations Open access
Semantic Scholar
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
E. Díaz-Rubio, J. Sastre, A. Abad, M. Navarro +9 more
1999Oncology23 citations
Semantic Scholar
Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation.
E. Pieras, J. Palou, J. Salvador, A. Rosales +2 more
2003European Urology22 citations
Semantic Scholar
Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study.
Enrique Aranda, Manuel Valladares, Mercedes Martinez-Villacampa, M. Benavides +10 more
2009Annals of Oncology20 citations Open access
Semantic Scholar
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study
A. Abad, B. Massutí, A. Antón, M. Vega +10 more
2008Acta oncologica20 citations Open access
Semantic Scholar
Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer
M. Palicio, I. Blanco, S. Tórtola, I. González +6 more
2000British Journal of Cancer20 citations Open access
Semantic Scholar
Carboplatin for advanced bladder cancer.
E. Marcuello, M. A. Izquierdo, J. Germá, C. Solà +4 more
1990European Journal of Cancer16 citations
Semantic Scholar
Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy.
L. Paré, D. Páez, J. Salazar, E. del Río +3 more
2010British Journal of Clinical Pharmacology15 citations Open access
Semantic Scholar
Systemic contact dermatitis from 5–fluorouracil
C. Nadal, Ramón M. Pujol, Liliana Randazzo, E. Marcuello +1 more
1996Contact Dermatitis14 citations
Semantic Scholar
Bladder Preservation Strategy Based on Combined Therapy in Patients with Muscle-Invasive Bladder Cancer: Management and Results at Long-Term Follow-Up
H. Villavicencio, O. Rodriguez-Faba, J. Palou, L. Gausa +2 more
2010Urologia internationalis13 citations
Semantic Scholar
UFT Plus Oral Folinic Acid as Therapy for Metastatic Colorectal Cancer in Older Patients
A. Abad, C. Martín, M. Navarro, J. Sastre +5 more
199713 citations
Semantic Scholar
Resectability of liver metastases (LM) in patients with advanced colorectal cancer (ACRA) after treatment with the combination of oxaliplatin (OXA), irinotecan (IRI) and 5FU. Final results of a phase II study
A. Abad, A. Antón, B. Massutí, F. Rivera +6 more
200512 citations
Semantic Scholar
Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin?
L. Paré, E. Marcuello, Albert Altés, E. del Río +3 more
2008The Pharmacogenomics Journal11 citations
Semantic Scholar
Analysis of differential gene expression in human colorectal tumor tissues by RNA arbitrarily primed-PCR: a technical assessment.
S. Tórtola, G. Capellá, E. Marcuello, K. Günther +4 more
1998Laboratory investigation; a journal of technical methods and pathology11 citations
Semantic Scholar
Radioimmunolocalization of colorectal carcinoma. A correlation among RIL results, surgical findings, serum tumor marker levels and the presence of CEA and CA 19.9 in tumor tissue: the experience of the Hospital de la Santa Creu i Sant Pau.
J. Germá-Lluch, I. Alvarez, Ignasi Carrió, F. Nogueras +3 more
1991Annals of Oncology11 citations Open access
Semantic Scholar
Mismatch repair gene analysis in Catalonian families with colorectal cancer
M. Palicio, J. Balmaña, S. González, I. Blanco +7 more
2002Journal of Medical Genetics9 citations Open access
Semantic Scholar
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer
A. Carrato, A. Gómez, Pilar Escudero, M. Chaves +14 more
2013Clinical and Translational Oncology8 citations Open access
Semantic Scholar
4004 Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status – the TTD-06–01 Spanish Cooperative Group trial
F. Rivera, C. Grávalos, B. Massutí, J. Puente +6 more
20098 citations
Semantic Scholar
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females.
L. Paré, J. Salazar, E. del Río, M. Baiget +4 more
2008Journal of Clinical Oncology8 citations Open access
Semantic Scholar
Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer.
A. Abad, A. Carrato, M. Navarro, J. Sastre +9 more
2005Clinical colorectal cancer8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. del Río×11
Invite
E. del Río — researcher profile on SciRah
E. Aranda×11
Invite
E. Aranda — researcher profile on SciRah
B. Massutí×10
Invite
B. Massutí — researcher profile on SciRah
A. Abad×10
Invite
A. Abad — researcher profile on SciRah

×9

Invite

E. Díaz-Rubio — researcher profile on SciRah

Invite

M. Baiget — researcher profile on SciRah

Invite

L. Paré — researcher profile on SciRah

Invite

A. Carrato — researcher profile on SciRah

Invite

G. Capellá — researcher profile on SciRah

Invite

M. Peinado — researcher profile on SciRah

M. Benavides×7

Invite

M. Benavides — researcher profile on SciRah

Invite

J. Salazar — researcher profile on SciRah